Skip to main content
. Author manuscript; available in PMC: 2015 Mar 12.
Published in final edited form as: Endocr Pract. 2009 Nov-Dec;15(7):705–713. doi: 10.4158/EP08178.ORR

Fig. 1.

Fig. 1

Percentage change in bone mineral density (BMD) at 3 anatomic sites in men receiving placebo in comparison with men receiving alendronate (“active treatment”).